Arcturus Therapeutics initiates phase 3b study of ARCT-154 vaccines in Vietnam

Arcturus Therapeutics initiates phase 3b study of ARCT-154 vaccines in Vietnam

Arcturus Therapeutics Holdings Inc. has got the nod from the Ministry of Health to start phase 3b study of ARCT-154 self-replicating RNA vaccine in Vietnam.
Arcturus Therapeutics ties up with Vingroup for vaccine manufacturing plant in Vietnam

Arcturus Therapeutics ties up with Vingroup for vaccine manufacturing plant in Vietnam

Arcturus announced will collaborate with Vingroup's Vinbiocare to establish a manufacturing facility in Vietnam for COVID-19 vaccines.